Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca2+ and K+ channels

被引:17
作者
Keating, DJ
Rychkov, GY
Adams, MB
Holgert, H
McMillen, IC
Roberts, ML [1 ]
机构
[1] Univ Adelaide, Discipline Physiol, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia
[2] Karolinska Inst, Dept Woman & Child Hlth, S-17177 Stockholm, Sweden
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2004年 / 555卷 / 02期
关键词
D O I
10.1113/jphysiol.2003.056176
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Before the preganglionic regulation of the adrenal medulla is established, hypoxia acts directly on the chromaffin cells to evoke the secretion of catecholamines. This direct action of hypoxia is suppressed by the gradual development of the preganglionic innervation and we have proposed that opioid peptides released from the adrenal splanchnic nerves may be responsible for this suppression. The effects of the specific opioid agonists DPDPE (delta-agonist), U-62066 (kappa-agonist) and DALDA (mu-agonist) on the hypoxia-evoked response were investigated in both a whole-gland preparation and in isolated adrenal chromaffin cells using amperometry, whole-cell patch clamping and measurement of cytosolic [Ca2+]. The combined application of mu- and kappa-type agonists abolished the hypoxia-evoked catecholamine secretion from whole perfused adrenal gland. In isolated chromaffin cells, mu- and kappa-opioid agonists reduced the rise in [Ca2+](i) that results from exposure to hypoxia. Both agonists decreased the voltage-dependent Ca2+ current in these cells. The mu-agonist increased the conductance through SK-type K+ channels and this action offset the decrease in K+ conductance produced by exposure to hypoxia. The kappa-type agonist decreased the conductance through an action on BK-type K+ channels, a class of channels that are not involved in initiating the direct response to hypoxia. These data suggest that opioids, through their action on SK channels and voltage-dependent Ca2+ channels, may be responsible for the nerve-induced suppression of the hypoxic response of adrenal chromaffin cells and that these effects of endogenous opioids are mediated via mu- and kappa-type receptors.
引用
收藏
页码:489 / 502
页数:14
相关论文
共 33 条
[1]   The non-neurogenic catecholamine response of the fetal adrenal to hypoxia is dependent on activation of voltage sensitive Ca2+ channels [J].
Adams, MB ;
Simonetta, G ;
McMillen, IC .
DEVELOPMENTAL BRAIN RESEARCH, 1996, 94 (02) :182-189
[2]   Opioid inhibition of Ca2+ channel subtypes in bovine chromaffin cells: Selectivity of action and voltage dependence [J].
Albillos, A ;
Carbone, E ;
Gandia, L ;
Garcia, AG ;
Pollo, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (08) :1561-1570
[4]   THE DISTRIBUTION OF OPIOID BINDING SUBTYPES IN THE BOVINE ADRENAL-MEDULLA [J].
BUNN, SJ ;
MARLEY, PD ;
LIVETT, BG .
NEUROSCIENCE, 1988, 27 (03) :1081-1094
[5]   INTERACTION OF OPIATES WITH OPIOID BINDING-SITES IN THE BOVINE ADRENAL-MEDULLA .1. INTERACTION WITH DELTA-SITES AND MU-SITES [J].
CASTANAS, E ;
BOURHIM, N ;
GIRAUD, P ;
BOUDOURESQUE, F ;
CANTAU, P ;
OLIVER, C .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (03) :677-687
[6]   MU-OPIOID AND KAPPA-OPIOID INHIBIT TRANSMITTER RELEASE BY DIFFERENT MECHANISMS [J].
CHERUBINI, E ;
NORTH, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) :1860-1863
[7]   FETAL ADRENAL-MEDULLA CATECHOLAMINE RESPONSE TO HYPOXIA-DIRECT AND NEURAL COMPONENTS [J].
CHEUNG, CY .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (06) :R1340-R1346
[8]   Phospholipase C-mediated signalling is not required for histamine-induced catecholamine secretion from bovine chromaffin cells [J].
Donald, AN ;
Wallace, DJ ;
McKenzie, S ;
Marley, PD .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (05) :1116-1129
[9]   OPIOID RECEPTORS IN BOVINE ADRENAL-MEDULLA [J].
DUMONT, M ;
LEMAIRE, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (10) :1284-1291
[10]   International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: Potassium channels [J].
Gutman, GA ;
Chandy, KG ;
Adelman, JP ;
Aiyar, J ;
Bayliss, DA ;
Clapham, DE ;
Covarriubias, M ;
Desir, GV ;
Furuichi, K ;
Ganetzky, B ;
Garcia, ML ;
Grissmer, S ;
Jan, LY ;
Karschin, A ;
Kim, D ;
Kuperschmidt, S ;
Kurachi, Y ;
Lazdunski, M ;
Lesage, F ;
Lester, HA ;
Mckinnon, D ;
Nichols, CG ;
O'Kelly, I ;
Robbins, J ;
Robertson, GA ;
Rudy, B ;
Sanguinetti, M ;
Seino, S ;
Stuehmer, W ;
Tamkun, MM ;
Vandenberg, CA ;
Wei, A ;
Wulff, H ;
Wymore, RS .
PHARMACOLOGICAL REVIEWS, 2003, 55 (04) :583-586